Found: 17
Select item for more details and to access through your institution.
Nuclear medicine imaging for bone metastases assessment: what else besides bone scintigraphy in the era of personalized medicine?
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2023.1320574
- By:
- Publication type:
- Article
High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1699, doi. 10.2967/jnumed.123.265584
- By:
- Publication type:
- Article
<sup>18</sup>F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 12, p. 1865, doi. 10.2967/jnumed.122.263984
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluorodihydroxyphenylalanine PET/CT at the Forefront for Initial and/or Pre-surgical Evaluation of Small Intestine Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.263984
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluorodihydroxyphenylalanine PET/CT at the Forefront for Initial and/or Pre-surgical Evaluation of Small Intestine Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.263984
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluorodihydroxyphenylalanine PET/CT at the Forefront for Initial and/or Pre-surgical Evaluation of Small Intestine Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.122.263984
- By:
- Publication type:
- Article
Values of <sup>68</sup>Ga-DOTATOC and Carbidopa-assisted <sup>18</sup>F-DOPA PET/CT for insulinoma localization.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262401
- By:
- Publication type:
- Article
Values of <sup>68</sup>Ga-DOTATOC and Carbidopa-assisted <sup>18</sup>F-DOPA PET/CT for insulinoma localization.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262401
- By:
- Publication type:
- Article
Values of <sup>68</sup>Ga-DOTATOC and Carbidopa-assisted <sup>18</sup>F-DOPA PET/CT for insulinoma localization.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262401
- By:
- Publication type:
- Article
Values of <sup>68</sup>Ga-DOTATOC and Carbidopa-assisted <sup>18</sup>F-DOPA PET/CT for insulinoma localization.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262401
- By:
- Publication type:
- Article
Values of <sup>68</sup>Ga-DOTATOC and Carbidopa-assisted <sup>18</sup>F-DOPA PET/CT for insulinoma localization.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.262401
- By:
- Publication type:
- Article
Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 5, p. e2056, doi. 10.1210/clinem/dgab891
- By:
- Publication type:
- Article
Performance of [<sup>18</sup>F]fluorocholine PET/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent/recurrent disease.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1349, doi. 10.1007/s00259-023-06537-1
- By:
- Publication type:
- Article
Cutting-Edge Imaging of Cardiac Metastases from Neuroendocrine Tumors: Lesson from a Case Series.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 5, p. N.PAG, doi. 10.3390/diagnostics12051182
- By:
- Publication type:
- Article
Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine Procedures.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6368, doi. 10.3390/cancers13246368
- By:
- Publication type:
- Article
A bicentric retrospective study of the correlation of EAU BCR risk groups with <sup>18</sup>F-PSMA-1007 PET/CT detection in prostate cancer biochemical recurrence.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-61121-3
- By:
- Publication type:
- Article
Intraindividual comparison of <sup>18</sup>F‐FDOPA and <sup>68</sup>Ga‐DOTATOC PET/CT detection rate for metastatic assessment in patients with ileal neuroendocrine tumours.
- Published in:
- Clinical Endocrinology, 2021, v. 94, n. 1, p. 66, doi. 10.1111/cen.14312
- By:
- Publication type:
- Article